Document is current
Any future updates will be listed below
-
Authors
Seal, Srijit https://orcid.org/0000-0003-2790-8679
Dee, William https://orcid.org/0000-0003-0663-6547
Shah, Adit https://orcid.org/0000-0002-0586-249X
Cerisier, Natacha https://orcid.org/0000-0001-8709-4561
Zhang, Andrew https://orcid.org/0000-0002-9432-2793
Miglietta, Esteban
Titterton, Katherine
Cabrera, Ángel Alexander
Boiko, Daniil
Beatson, Alex
Slabaugh, Gregory
Taboureau, Olivier
Carreras Puigvert, Jordi
Singh, Shantanu
Spjuth, Ola https://orcid.org/0000-0002-8083-2864
Bender, Andreas https://orcid.org/0000-0002-6683-7546
Carpenter, Anne E. https://orcid.org/0000-0003-1555-8261
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 9 January 2026
First Online: 6 February 2026
Competing interests
: S. Singh and A.E.C. serve as scientific advisors for companies that use image-based profiling and Cell Painting (A.E.C.: Recursion, SyzOnc, Quiver Bioscience; S. Singh: Waypoint Bio, Dewpoint Therapeutics, DeepCell) and receive honoraria for occasional talks at pharmaceutical and biotechnology companies. J.C.P. and O.S. declare ownership in Phenaros Pharmaceuticals. G.S. serves as a scientific advisor to BioAIHealth and has a collaborative project with AstraZeneca involving image-based profiling and Cell Painting. The remaining authors declare no competing interests.
